Cancer Proliferation Gene Discovery Through Functional Genomics

Michael R. Schlabach(Brigham and Women's Hospital), Ji Luo(Brigham and Women's Hospital), Nicole L. Solimini(Brigham and Women's Hospital), Guang Hu(Brigham and Women's Hospital), Qikai Xu(Brigham and Women's Hospital), Mamie Z. Li(Brigham and Women's Hospital), Zhenming Zhao(Brigham and Women's Hospital), Agata Smogorzewska(Brigham and Women's Hospital), Mathew E. Sowa(Brigham and Women's Hospital), Xiaolu L. Ang(Brigham and Women's Hospital), Thomas F. Westbrook(Brigham and Women's Hospital), Anthony C. Liang(Brigham and Women's Hospital), Kenneth Chang(Brigham and Women's Hospital), Jennifer A. Hackett(Brigham and Women's Hospital), J. Wade Harper(Brigham and Women's Hospital), Gregory J. Hannon(Brigham and Women's Hospital), Stephen J. Elledge(Brigham and Women's Hospital)
Science
February 1, 2008
Cited by 386Open Access
Full Text

Abstract

Retroviral short hairpin RNA (shRNA)-mediated genetic screens in mammalian cells are powerful tools for discovering loss-of-function phenotypes. We describe a highly parallel multiplex methodology for screening large pools of shRNAs using half-hairpin barcodes for microarray deconvolution. We carried out dropout screens for shRNAs that affect cell proliferation and viability in cancer cells and normal cells. We identified many shRNAs to be antiproliferative that target core cellular processes, such as the cell cycle and protein translation, in all cells examined. Moreover, we identified genes that are selectively required for proliferation and survival in different cell lines. Our platform enables rapid and cost-effective genome-wide screens to identify cancer proliferation and survival genes for target discovery. Such efforts are complementary to the Cancer Genome Atlas and provide an alternative functional view of cancer cells.


Related Papers

No related papers found

Powered by citation graph analysis